Better care for people with pseudoxanthoma elasticum
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Skin clinical trials.
This study looks at whether a new way of organizing care helps patients with pseudoxanthoma elasticum (PXE). It also asks some patients about their experience with the new care setup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of pseudoxanthoma elasticum (PXE), either through skin/eye exams or genetic testing.
- You are being treated at the specialized center (CRMR) during the study periods.
- You agree to take part in the research and are not under any legal guardianship or protection.
- For the interview part: you were already seen before the new care system started and you agree to be recorded.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a compound that affects certain chemicals in your body (purines) to see if it helps people with pseudoxanthoma elasticum (PXE), a rare genetic condition affecting skin, eyes, and blood vessels.
This study looks at blood flow in a layer of the eye called the choriocapillaris in people with pseudoxanthoma elasticum (PXE). It compares these findings with healthy volunteers to understand eye changes before they become severe.
This trial studies whether taking PPI-type supplements can slow or reduce unwanted calcification in people with PXE. It’s meant to help manage disease changes caused by abnormal calcium deposits, based on your medical testing.
This Phase 3 study tests a medicine to help prevent abnormal calcium (called ectopic mineralization) from building up in people with pseudoxanthoma elasticum (PXE). It aims to slow or reduce new damage over time.
This study uses special eye imaging to track changes caused by PXE, a rare genetic condition. It may help researchers understand how PXE affects the eyes over time.
This study compares a tailored “maintenance” treatment plan to the usual standard care in adults with newly diagnosed pemphigus (PV or PF). It aims to see whether the personalized approach can help control the disease while reducing the burden of long-term treatment.
Hear when a new Pseudoxanthoma Elasticum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.